STOCK TITAN

Redmile Group (NRIX) discloses 8.1% Nurix stake including pre-funded warrants

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Redmile Group, LLC and related entities report significant ownership in Nurix Therapeutics, Inc. Redmile Group, LLC and its principal, Jeremy C. Green, each report beneficial ownership of 8,782,256 shares of Nurix common stock, representing 8.1% of the class. This stake consists of 4,073,787 outstanding shares and 4,708,469 shares issuable upon exercise of pre-funded warrants held by investment vehicles managed by Redmile. RedCo II Offshore SPV LLC, one such vehicle, reports beneficial ownership of 3,712,546 shares, or 3.5%, including shares issuable upon warrant exercise. Beneficial ownership percentages are based on 103,781,683 shares outstanding as of June 30, 2026, plus the relevant warrant shares. Voting and dispositive powers are reported as shared, with Redmile and Mr. Green disclaiming beneficial ownership beyond their pecuniary interest.

Positive

  • None.

Negative

  • None.
Beneficial ownership – Redmile Group, LLC 8,782,256 shares Nurix common stock beneficially owned, as of June 30, 2026
Beneficial ownership – Jeremy C. Green 8,782,256 shares Nurix common stock beneficially owned, mirroring Redmile’s reported position
Beneficial ownership – RedCo II Offshore SPV LLC 3,712,546 shares Nurix common stock beneficially owned through shares and warrants
Ownership percentage – Redmile/Jeremy C. Green 8.1% Percent of Nurix common stock class, including 4,708,469 warrant shares
Ownership percentage – RedCo II Offshore 3.5% Percent of Nurix common stock class, including 2,881,142 warrant shares
Shares outstanding baseline 103,781,683 shares Nurix common stock outstanding as of June 30, 2026 per Form 10-Q
beneficially own financial
"Amount beneficially owned: Redmile Group, LLC - 8,782,256"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
pre-funded warrants financial
"shares of Common Stock issuable upon exercise of certain pre-funded warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
shared voting power financial
"Shared Voting Power 8,782,256.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 8,782,256.00"
Schedule 13G regulatory
"If a parent holding company has filed this schedule, pursuant to"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What ownership stake in Nurix Therapeutics (NRIX) does Redmile Group report?

Redmile Group, LLC and Jeremy C. Green each report beneficial ownership of 8,782,256 shares of Nurix common stock, representing 8.1% of the outstanding class, including shares underlying pre-funded warrants managed through Redmile investment funds.

How many Nurix (NRIX) shares does RedCo II Offshore SPV LLC beneficially own?

RedCo II Offshore SPV LLC reports beneficial ownership of 3,712,546 shares of Nurix common stock, representing 3.5% of the class. This includes 831,404 outstanding shares and 2,881,142 shares issuable upon exercise of pre-funded warrants it directly holds.

How are Redmile’s Nurix (NRIX) holdings structured between stock and warrants?

Redmile’s reported beneficial ownership includes 4,073,787 outstanding Nurix common shares and 4,708,469 shares issuable upon exercise of pre-funded warrants. These securities are held by various Redmile-managed funds, including RedCo II Offshore SPV LLC, for which Redmile acts as investment manager.

What share count underlies the ownership percentages in this Nurix (NRIX) Schedule 13G/A?

The reported ownership percentages use a base of 103,781,683 Nurix common shares outstanding as of June 30, 2026, as disclosed in Nurix’s Form 10-Q, plus the additional shares issuable upon exercise of the relevant pre-funded warrants held by Redmile-managed funds.

Do Redmile Group and Jeremy C. Green have sole or shared voting power over Nurix (NRIX) shares?

Redmile Group and Jeremy C. Green report 0 shares with sole voting or dispositive power and 8,782,256 shares with shared voting and dispositive power, reflecting their roles as investment manager and principal of the Redmile-managed funds holding the Nurix securities.

Do Redmile Group and Jeremy C. Green disclaim any Nurix (NRIX) beneficial ownership?

Yes. Redmile Group and Jeremy C. Green state they disclaim beneficial ownership of the Nurix securities held by the Redmile funds, except to the extent of their pecuniary interest in such securities, if any, despite reporting them as beneficially owned for Schedule 13G purposes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





67080M103

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The information in Item 4 relating to the shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), that are or may be deemed beneficially owned by Redmile Group, LLC and the calculation of the percent of such class of securities is incorporated herein by reference.


SCHEDULE 13G




Comment for Type of Reporting Person: The information in Item 4 relating to the shares of Common Stock that are or may be deemed beneficially owned by Jeremy C. Green and the calculation of the percent of such class of securities is incorporated herein by reference.


SCHEDULE 13G




Comment for Type of Reporting Person: The information in Item 4 relating to the shares of Common Stock that are or may be deemed beneficially owned by RedCo II Offshore SPV LLC and the calculation of the percent of such class of securities is incorporated herein by reference.


SCHEDULE 13G



Redmile Group, LLC
Signature:/s/ Jeremy C. Green
Name/Title:Managing Member
Date:08/14/2026
Jeremy C. Green
Signature:/s/ Jeremy C. Green
Name/Title:Jeremy C. Green
Date:08/14/2026
RedCo II Offshore SPV LLC
Signature:/s/ Jeremy C. Green
Name/Title:Managing Member of Redmile Group, LLC, its manager
Date:08/14/2026